Gao L - Search Results

1

A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.

Li F, Hu Y, Zhou Y, Chen L, Xia W, Song Y, Tan Z, Gao L, Yang Z, Zeng G, Han X, Li J, Li J. Li F, et al. Among authors: gao l. Pediatr Infect Dis J. 2017 May;36(5):e157-e161. doi: 10.1097/INF.0000000000001535. Pediatr Infect Dis J. 2017. PMID: 28060048 Clinical Trial.

2

[Laboratory diagnosis and molecular characterization of highly pathogenic avian influenza virus (H5N1) in human in Hunan Province in 2005-2006].

Huang YW, Li Z, Zhang H, Liu YZ, Wen LY, Li JH, Gao LD, Zhao XS, Li ZJ, Chen BY, Lan Y, Zhou L, Shu YL. Huang YW, et al. Among authors: gao ld. Bing Du Xue Bao. 2007 Nov;23(6):434-9. Bing Du Xue Bao. 2007. PMID: 18092679 Chinese.

3

[Molecular characterization of highly pathogenic avian influenza A (H5N1) viruses isolated from humans in Hunan province, 2006 - 2009].

Huang YW, Dong LB, Li JH, Liu YZ, Gao LD, Zhang H, Chen Z, Hu SX, Li FC, Shu YL. Huang YW, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Jul;32(7):709-15. Zhonghua Liu Xing Bing Xue Za Zhi. 2011. PMID: 21933546 Chinese.

4

Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.

Ma C, Li F, Zheng X, Zhang H, Duan M, Yang Y, Hao L, Su Q, Rodewald L, Guo B, Xiao S, Wang H, Li L, Li J, Luo H, Gao L. Ma C, et al. Among authors: gao l. BMC Infect Dis. 2015 Jan 22;15:23. doi: 10.1186/s12879-015-0752-z. BMC Infect Dis. 2015. PMID: 25608672 Free PMC article.

5

Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.

Yang S, Li Y, Dai L, Wang J, He P, Li C, Fang X, Wang C, Zhao X, Huang E, Wu C, Zhong Z, Wang F, Duan X, Tian S, Wu L, Liu Y, Luo Y, Chen Z, Li F, Li J, Yu X, Ren H, Liu L, Meng S, Yan J, Hu Z, Gao L, Gao GF. Yang S, et al. Among authors: gao gf, gao l. Lancet Infect Dis. 2021 Aug;21(8):1107-1119. doi: 10.1016/S1473-3099(21)00127-4. Epub 2021 Mar 24. Lancet Infect Dis. 2021. PMID: 33773111 Free PMC article. Clinical Trial.

6

Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in China.

Liu X, Chang S, Wang R, Xiao Y, Li F, Xu Q, Zhang S, Chen X, Zhang S, Zhang M, Chen X, Cao Q, Liu X, Wang H, Zhan D, Chen H, Chen W, Jiang J, Zhang C, Wang H, Gao L, Shi X, Yang X, Xu A. Liu X, et al. Among authors: gao l. Vaccines (Basel). 2022 Jun 2;10(6):895. doi: 10.3390/vaccines10060895. Vaccines (Basel). 2022. PMID: 35746502 Free PMC article.

7

Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial.

Gao L, Li Y, He P, Chen Z, Yang H, Li F, Zhang S, Wang D, Wang G, Yang S, Gong L, Ding F, Ling M, Wang X, Ci L, Dai L, Gao GF, Huang T, Hu Z, Ying Z, Sun J, Zuo X. Gao L, et al. Among authors: gao gf. Lancet Child Adolesc Health. 2023 Apr;7(4):269-279. doi: 10.1016/S2352-4642(22)00376-5. Epub 2023 Feb 17. Lancet Child Adolesc Health. 2023. PMID: 36803632 Free PMC article. Clinical Trial.

8

Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine KCONVAC in Chinese Children: Randomized, Double-blind, Placebo-controlled Phase 1 and 2 Trials.

Liu J, Huang B, Li G, Huang T, Wang D, Zhang L, Deng Y, Chang X, Liu Y, Li W, Zhang S, Huang W, Tan W, Gao L. Liu J, et al. Among authors: gao l. Pediatr Infect Dis J. 2023 Dec 1;42(12):1136-1142. doi: 10.1097/INF.0000000000004085. Epub 2023 Sep 4. Pediatr Infect Dis J. 2023. PMID: 37967148 Clinical Trial.

9

Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trial.

Huang T, Yu J, Zhang S, Teng D, Dai D, Zhu Y, Gao L. Huang T, et al. Among authors: gao l. Hum Vaccin Immunother. 2024 Dec 31;20(1):2330770. doi: 10.1080/21645515.2024.2330770. Epub 2024 Apr 11. Hum Vaccin Immunother. 2024. PMID: 38602539 Free PMC article. Clinical Trial.

10

Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial.

Huang T, Hu Q, Zhou X, Yang H, Xia W, Cao F, Deng M, Teng X, Ding F, Zhong Z, Gao L, Sun J, Gong L. Huang T, et al. Among authors: gao l. BMC Infect Dis. 2024 Apr 19;24(1):413. doi: 10.1186/s12879-024-09293-1. BMC Infect Dis. 2024. PMID: 38641791 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,245 results

Search Page